The Latest Breaking News from HIV

Mark Ward, a victim of the infected blood scandal that has killed so many, has fought all his life for truth and acknowledgement of what happened to him and so many of his peers. Now, at last, his voice is being heard

As the UN’s climate summit, Cop29, gets underway in Azerbaijan this week, the effect of climate change on human health is high on the agenda. And rightly so, amid some alarming emerging statistics. By the end of this century, climate change could be the cause of more than 3 million…

The drugmaker said sales of Arexvy fell sharply in the third quarter, but cancer and HIV treatments saw a stronger performance.

There are many myths about breast cancer, particularly in Africa with its rich diversity of people, different genetic backgrounds and ancestral histories.

Recent study supports safe kidney transplants between HIV-positive individuals, potentially reducing wait times and improving organ access.

A new study found people with HIV can safely receive donated kidneys from deceased donors with the virus

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

On Call, Anthony Fauci's new memoir, can't disguise the damage caused by his COVID-19 policies.

A new drug to prevent HIV infection is showing hugely promising results in clinical trials when injected every six months.